Induction of oral tolerance to the acetylcholine receptor for treatment of myasthenia gravis
Open Access
- 15 December 1999
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 104 (12) , 1667-1668
- https://doi.org/10.1172/jci8775
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragmentJournal of Clinical Investigation, 1999
- Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravisJournal of Clinical Investigation, 1999
- Induction of Autoimmune Diabetes by Oral Administration of AutoantigenScience, 1996
- Peripheral deletion of antigen-reactive T cells in oral toleranceNature, 1995
- Oral administration of acetylcholine receptor: Effects on experimental myasthenia gravisAnnals of Neurology, 1994
- Published by American Association for the Advancement of Science (AAAS) ,1994
- Myasthenia GravisNew England Journal of Medicine, 1994
- Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animalsEuropean Journal of Immunology, 1994
- The regulation of immune responses to dietary protein antigensImmunology Today, 1987
- Myasthenia GravisNew England Journal of Medicine, 1977